DE69433663D1 - Antikörper gegen menschliches prostatspezifisches drüsenkallikrein - Google Patents

Antikörper gegen menschliches prostatspezifisches drüsenkallikrein

Info

Publication number
DE69433663D1
DE69433663D1 DE69433663T DE69433663T DE69433663D1 DE 69433663 D1 DE69433663 D1 DE 69433663D1 DE 69433663 T DE69433663 T DE 69433663T DE 69433663 T DE69433663 T DE 69433663T DE 69433663 D1 DE69433663 D1 DE 69433663D1
Authority
DE
Germany
Prior art keywords
human prostate
callic
rein
antibodies against
against human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433663T
Other languages
English (en)
Other versions
DE69433663T2 (de
Inventor
J Tindall
Y Young
G Klee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Original Assignee
Mayo Foundation for Medical Education and Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research filed Critical Mayo Foundation for Medical Education and Research
Publication of DE69433663D1 publication Critical patent/DE69433663D1/de
Application granted granted Critical
Publication of DE69433663T2 publication Critical patent/DE69433663T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
DE69433663T 1993-07-22 1994-06-29 Antikörper gegen menschliches prostatspezifisches drüsenkallikrein Expired - Lifetime DE69433663T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/096,946 US5516639A (en) 1993-07-22 1993-07-22 Antibodies specific for human prostate glandular kallkrein
US96946 1993-07-22
PCT/US1994/007329 WO1995003334A1 (en) 1993-07-22 1994-06-29 Antibodies specific for human prostate glandular kallikrein

Publications (2)

Publication Number Publication Date
DE69433663D1 true DE69433663D1 (de) 2004-05-06
DE69433663T2 DE69433663T2 (de) 2004-08-19

Family

ID=22259880

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433663T Expired - Lifetime DE69433663T2 (de) 1993-07-22 1994-06-29 Antikörper gegen menschliches prostatspezifisches drüsenkallikrein

Country Status (11)

Country Link
US (1) US5516639A (de)
EP (1) EP0710253B1 (de)
JP (1) JPH09501152A (de)
AT (1) ATE263189T1 (de)
AU (1) AU693457B2 (de)
DE (1) DE69433663T2 (de)
DK (1) DK0710253T3 (de)
ES (1) ES2215997T3 (de)
PT (1) PT710253E (de)
WO (1) WO1995003334A1 (de)
ZA (1) ZA945364B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786148A (en) * 1996-11-05 1998-07-28 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a novel prostate-specific kallikrein
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US20040259113A1 (en) * 1993-07-22 2004-12-23 Mayo Foundation For Medical Education And Research, Hybritech Incorporated Method for detection of metastatic prostate cancer
WO1995030758A1 (en) * 1994-05-10 1995-11-16 Mayo Foundation For Medical Education And Research Recombinant hk2 polypeptide
US5614372A (en) * 1995-02-24 1997-03-25 Lilja; Hans Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
GB2302874B (en) * 1995-06-29 1999-11-10 Orion Yhtymae Oy Novel proteins
US6143509A (en) * 1996-02-06 2000-11-07 Abbott Laboratories Prostate specific antigen peptides and uses thereof
US6946133B1 (en) * 1996-03-20 2005-09-20 The United States Of America As Represented By The Department Of Health And Human Services Prostate specific antigen oligo-epitope peptide
ATE305140T1 (de) * 1996-07-15 2005-10-15 Mayo Foundation Verfahren zur detektion der hk2 polypeptide
AU4086397A (en) * 1996-09-06 1998-03-26 Centocor Inc. Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen
US6479263B1 (en) 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
US5840871A (en) * 1997-01-29 1998-11-24 Incyte Pharmaceuticals, Inc. Prostate-associated kallikrein
AU8259798A (en) 1997-06-20 1999-01-04 George G Klee Method for detection of breast cancer
US6280742B1 (en) 1998-06-17 2001-08-28 Zonagen, Inc. Methods and materials for the treatment of prostatic carcinoma
WO2000044940A2 (en) 1999-01-28 2000-08-03 Gen-Probe Incorporated Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
US7195759B2 (en) * 2001-06-06 2007-03-27 The University Of Manitoba Therapeutic uses of glandular kallikrein
US20090162342A1 (en) * 2001-06-07 2009-06-25 Sanomune Inc. Therapeutic uses of glandular kallikrein
IL150601A (en) * 2001-07-19 2010-06-30 Organon Nv Process for rapid synthesis of peptides within a solution using the back of an activated carboxyl component and destruction of the residual activated carboxyl component
TWI243826B (en) * 2001-07-19 2005-11-21 Akzo Nobel Nv Process for the preparation of peptides
US20040009503A1 (en) * 2002-07-03 2004-01-15 Molecular Staging, Inc. Immune modulatory activity of human ribonucleases
CA2514089A1 (en) * 2002-11-18 2004-06-03 The Johns Hopkins University Activation of peptide prodrugs by hk2
US8663600B2 (en) * 2005-02-17 2014-03-04 Diaprost Ab Diagnosis of prostate cancer
ES2687620T3 (es) 2007-05-04 2018-10-26 Opko Diagnostics, Llc Dispositivo y método para análisis en sistemas microfluídicos
WO2010087999A1 (en) * 2009-02-02 2010-08-05 Claros Diagnostics, Inc. Structures for controlling light interaction with microfluidic devices
US8658164B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US20130116131A1 (en) 2011-11-08 2013-05-09 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8658166B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
CN104364788B (zh) 2012-03-05 2018-02-06 阿克蒂克合伙公司 预测前列腺癌风险及前列腺腺体体积的装置
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
LT2854841T (lt) 2012-06-04 2017-06-12 Diamedica Inc. Kalikreino 1 iš žmogaus audinio glikozilinimo izoformos
SG11201608035UA (en) 2014-03-28 2016-10-28 Opko Diagnostics Llc Compositions and methods related to diagnosis of prostate cancer
DK3253800T3 (da) 2015-03-27 2021-05-31 Opko Diagnostics Llc Prostata antigen standarder og bruge deraf
JP2020510023A (ja) 2017-03-09 2020-04-02 ダイアメディカ， インコーポレイテッド 組織カリクレイン１の剤形

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3901654A (en) * 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3862925A (en) * 1973-07-05 1975-01-28 American Home Prod Preparation of somatotropin release inhibiting factor and intermediates therefor
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
JPS5726506B2 (de) * 1974-03-08 1982-06-04
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) * 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US4105602A (en) * 1975-02-10 1978-08-08 Armour Pharmaceutical Company Synthesis of peptides with parathyroid hormone activity
US4092408A (en) * 1975-08-28 1978-05-30 New England Nuclear Corporation Method for solid phase immunological assay of antigen
US3984533A (en) * 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) * 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4353982A (en) * 1980-04-10 1982-10-12 Hoffmann-La Roche Inc. Immunochemical assay for creatine kinase-MB isoenzyme
US4792528A (en) * 1982-05-21 1988-12-20 The Trustees Of Columbia University In The City Of New York Methods for obtaining monoclonal antibodies useful in enhanced sensitivity immunoassays
US4487715A (en) * 1982-07-09 1984-12-11 The Regents Of The University Of California Method of conjugating oligopeptides
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4757048A (en) * 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides
AU627427B2 (en) * 1987-06-30 1992-08-27 Amgen, Inc. Production of kallikrein
WO1995030758A1 (en) * 1994-05-10 1995-11-16 Mayo Foundation For Medical Education And Research Recombinant hk2 polypeptide

Also Published As

Publication number Publication date
ATE263189T1 (de) 2004-04-15
WO1995003334A1 (en) 1995-02-02
AU7252594A (en) 1995-02-20
JPH09501152A (ja) 1997-02-04
EP0710253A1 (de) 1996-05-08
US5516639A (en) 1996-05-14
AU693457B2 (en) 1998-07-02
ZA945364B (en) 1995-03-13
PT710253E (pt) 2004-07-30
ES2215997T3 (es) 2004-10-16
DK0710253T3 (da) 2004-07-26
EP0710253B1 (de) 2004-03-31
DE69433663T2 (de) 2004-08-19

Similar Documents

Publication Publication Date Title
DE69433663D1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
TR200200472T2 (tr) Anti-Erb B2 antikorları ile tedavi için dozajlar
PT752876E (pt) Anticorpos monoclonicos que se conectam com o percursor antigeneo de rejeicao de tumores mage-1, mage-1 recombinante, e peptidos imunogenicos derivados de mage-1
BRPI0412245A (pt) anticorpos de rg1 e usos destes
ZA200501054B (en) Transplant acceptance inducing cells of monocytic origin and their preparation and use.
DK0677533T3 (da) Antistoffer mod epitoper med homologi til selv-antigener, fremgangsmåder til fremstilling og anvendelser deraf
DK0970126T3 (da) Hidtil ukendt fremgangsmåde til fremstillingen af anti-humant antigen-receptorer og anvendelser deraf
ATE208820T1 (de) Humanisierte antikoerper
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
ATE524196T1 (de) An das krebsassoziierte antigen cd46 bindende antikörper und verwendungsverfahren dafür
EE200700052A (et) Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu
ATE161582T1 (de) Monoklonale antikörper der maus
WO2002074251A3 (en) Monoclonal antibody therapy for pancreas cancer
KR900701318A (ko) 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체
DK0954529T3 (da) Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
ATE133994T1 (de) An karzinoma assoziierte antigene und antikörper, die diese antigene erkennen
AU2003225900A1 (en) Antibody disulfide isomers, use thereof, and methods of analyzing same
CA2165672A1 (en) Antibodies specific for human prostate glandular kallikrein
DE59209776D1 (de) Monoklonale Antikörper gegen tumorassoziierte Antigene, Verfahren zu ihrer Herstellung und ihre Verwendung
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
DE69827800D1 (de) Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
DK1399482T3 (da) Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger
GR890100333A (en) Antihuman antigen antibodies

Legal Events

Date Code Title Description
8364 No opposition during term of opposition